298 related articles for article (PubMed ID: 10594012)
21. Cooperative binding of DNA and CBFbeta to the Runt domain of the CBFalpha studied via MD simulations.
Habtemariam B; Anisimov VM; MacKerell AD
Nucleic Acids Res; 2005; 33(13):4212-22. PubMed ID: 16049027
[TBL] [Abstract][Full Text] [Related]
22. Alternative splicing removes an Ets interaction domain from Lozenge during Drosophila eye development.
Jackson Behan K; Fair J; Singh S; Bogwitz M; Perry T; Grubor V; Cunningham F; Nichols CD; Cheung TL; Batterham P; Pollock JA
Dev Genes Evol; 2005 Aug; 215(8):423-35. PubMed ID: 15868204
[TBL] [Abstract][Full Text] [Related]
23. Interaction of CBF alpha/AML/PEBP2 alpha transcription factors with nucleosomes containing promoter sequences requires flexibility in the translational positioning of the histone octamer and exposure of the CBF alpha site.
Gutiérrez J; Sierra J; Medina R; Puchi M; Imschenetzky M; van Wijnen A; Lian J; Stein G; Stein J; Montecino M
Biochemistry; 2000 Nov; 39(44):13565-74. PubMed ID: 11063594
[TBL] [Abstract][Full Text] [Related]
24. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.
Ogawa E; Inuzuka M; Maruyama M; Satake M; Naito-Fujimoto M; Ito Y; Shigesada K
Virology; 1993 May; 194(1):314-31. PubMed ID: 8386878
[TBL] [Abstract][Full Text] [Related]
25. Role of AML1/Runx1 in the pathogenesis of hematological malignancies.
Kurokawa M; Hirai H
Cancer Sci; 2003 Oct; 94(10):841-6. PubMed ID: 14556655
[TBL] [Abstract][Full Text] [Related]
26. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta.
Thirunavukkarasu K; Mahajan M; McLarren KW; Stifani S; Karsenty G
Mol Cell Biol; 1998 Jul; 18(7):4197-208. PubMed ID: 9632804
[TBL] [Abstract][Full Text] [Related]
27. A conserved cysteine residue in the runt homology domain of AML1 is required for the DNA binding ability and the transforming activity on fibroblasts.
Kurokawa M; Tanaka T; Tanaka K; Hirano N; Ogawa S; Mitani K; Yazaki Y; Hirai H
J Biol Chem; 1996 Jul; 271(28):16870-6. PubMed ID: 8663420
[TBL] [Abstract][Full Text] [Related]
28. Structures of SAP-1 bound to DNA targets from the E74 and c-fos promoters: insights into DNA sequence discrimination by Ets proteins.
Mo Y; Vaessen B; Johnston K; Marmorstein R
Mol Cell; 1998 Aug; 2(2):201-12. PubMed ID: 9734357
[TBL] [Abstract][Full Text] [Related]
29. Structural studies of Ets-1/Pax5 complex formation on DNA.
Garvie CW; Hagman J; Wolberger C
Mol Cell; 2001 Dec; 8(6):1267-76. PubMed ID: 11779502
[TBL] [Abstract][Full Text] [Related]
30. Multimerization via its myosin domain facilitates nuclear localization and inhibition of core binding factor (CBF) activities by the CBFbeta-smooth muscle myosin heavy chain myeloid leukemia oncoprotein.
Kummalue T; Lou J; Friedman AD
Mol Cell Biol; 2002 Dec; 22(23):8278-91. PubMed ID: 12417730
[TBL] [Abstract][Full Text] [Related]
31. Crystallization and preliminary X-ray analyses of quaternary, ternary and binary protein-DNA complexes with involvement of AML1/Runx-1/CBFalpha Runt domain, CBFbeta and the C/EBPbeta bZip region.
Tahirov TH; Inoue-Bungo T; Sasaki M; Shiina M; Kimura K; Sato K; Kumasaka T; Yamamoto M; Kamiya N; Ogata K
Acta Crystallogr D Biol Crystallogr; 2001 Jun; 57(Pt 6):850-3. PubMed ID: 11375505
[TBL] [Abstract][Full Text] [Related]
32. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11.
Kundu M; Chen A; Anderson S; Kirby M; Xu L; Castilla LH; Bodine D; Liu PP
Blood; 2002 Oct; 100(7):2449-56. PubMed ID: 12239155
[TBL] [Abstract][Full Text] [Related]
33. Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis.
Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Takeuchi K; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Blood; 2000 Nov; 96(9):3154-60. PubMed ID: 11049997
[TBL] [Abstract][Full Text] [Related]
34. Function of CBFbeta/Bro proteins.
Adya N; Castilla LH; Liu PP
Semin Cell Dev Biol; 2000 Oct; 11(5):361-8. PubMed ID: 11105900
[TBL] [Abstract][Full Text] [Related]
35. Modulation of transcription factor Ets-1 DNA binding: DNA-induced unfolding of an alpha helix.
Petersen JM; Skalicky JJ; Donaldson LW; McIntosh LP; Alber T; Graves BJ
Science; 1995 Sep; 269(5232):1866-9. PubMed ID: 7569926
[TBL] [Abstract][Full Text] [Related]
36. A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells.
Zhang YW; Bae SC; Huang G; Fu YX; Lu J; Ahn MY; Kanno Y; Kanno T; Ito Y
Mol Cell Biol; 1997 Jul; 17(7):4133-45. PubMed ID: 9199349
[TBL] [Abstract][Full Text] [Related]
37. Highly conserved amino acids in Pax and Ets proteins are required for DNA binding and ternary complex assembly.
Fitzsimmons D; Lutz R; Wheat W; Chamberlin HM; Hagman J
Nucleic Acids Res; 2001 Oct; 29(20):4154-65. PubMed ID: 11600704
[TBL] [Abstract][Full Text] [Related]
38. AML1 stimulates G1 to S progression via its transactivation domain.
Bernardin F; Friedman AD
Oncogene; 2002 May; 21(20):3247-52. PubMed ID: 12082641
[TBL] [Abstract][Full Text] [Related]
39. The leukemia-associated AML1 (Runx1)--CBF beta complex functions as a DNA-induced molecular clamp.
Bravo J; Li Z; Speck NA; Warren AJ
Nat Struct Biol; 2001 Apr; 8(4):371-8. PubMed ID: 11276260
[TBL] [Abstract][Full Text] [Related]
40. DNA recognition by the RUNX1 transcription factor is mediated by an allosteric transition in the RUNT domain and by DNA bending.
Bartfeld D; Shimon L; Couture GC; Rabinovich D; Frolow F; Levanon D; Groner Y; Shakked Z
Structure; 2002 Oct; 10(10):1395-407. PubMed ID: 12377125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
